Abstract
Dosage adjustments are often used to manage HIV drug interactions, but little is known about their clinical significance. We examined patients from the Ontario HIV Cohort Study to assess the effects of dosage adjustments on plasma viral load. A significant reduction (0.67 log 10 copies/mL) in viral load was associated with adjustments to manage efavirenz-based interactions (95% confidence interval, -1.33 to -0.01) but was not observed after adjustments to manage rifabutin-based (difference in viral load, 0.03 log 10 copies/mL; 95% confidence interval, -0.71 to 0.77) or nevirapine-based interactions (difference in viral load, 0.09 log 10 copies/mL; 95% confidence interval, -0.83 to 1.01). © 2007 by the Infectious Diseases Society of America. All rights reserved.
Cite
CITATION STYLE
Park-Wyllie, L. Y., Levine, M. A., Holbrook, A., Thabane, L., Antoniou, T., Yoong, D., … Bayoumi, A. M. (2007). Outcomes of dosage adjustments used to manage antiretroviral drug interactions. Clinical Infectious Diseases, 45(7), 933–936. https://doi.org/10.1086/521252
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.